Literature DB >> 36152122

Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy".

Joe Yeong1,2, Chong Boon Teo3, Ryan Yong Kiat Tay3, Benjamin Kye Jyn Tan3, Yiong Huak Chan4, Elizabeth C Smyth5, Raghav Sundar6,7,8,9,10.   

Abstract

Entities:  

Year:  2022        PMID： 36152122     DOI： 10.1007/s10120-022-01343-4

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.701


× No keyword cloud information.
  8 in total

1.  Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?

Authors:  Raghav Sundar; Patrick Tan
Journal:  Cancer Discov       Date:  2018-01       Impact factor: 39.397

2.  Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.

Authors:  Kohei Shitara; Mustafa Özgüroğlu; Yung-Jue Bang; Maria Di Bartolomeo; Mario Mandalà; Min-Hee Ryu; Lorenzo Fornaro; Tomasz Olesiński; Christian Caglevic; Hyun C Chung; Kei Muro; Eray Goekkurt; Wasat Mansoor; Raymond S McDermott; Einat Shacham-Shmueli; Xinqun Chen; Carlos Mayo; S Peter Kang; Atsushi Ohtsu; Charles S Fuchs
Journal:  Lancet       Date:  2018-06-04       Impact factor: 79.321

3.  PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

Authors:  Ming Sound Tsao; Keith M Kerr; Mark Kockx; Mary-Beth Beasley; Alain C Borczuk; Johan Botling; Lukas Bubendorf; Lucian Chirieac; Gang Chen; Teh-Ying Chou; Jin-Haeng Chung; Sanja Dacic; Sylvie Lantuejoul; Mari Mino-Kenudson; Andre L Moreira; Andrew G Nicholson; Masayuki Noguchi; Giuseppe Pelosi; Claudia Poleri; Prudence A Russell; Jennifer Sauter; Erik Thunnissen; Ignacio Wistuba; Hui Yu; Murry W Wynes; Melania Pintilie; Yasushi Yatabe; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2018-05-22       Impact factor: 15.609

4.  Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Authors:  Vikrant Kumar; Kalpana Ramnarayanan; Raghav Sundar; Nisha Padmanabhan; Supriya Srivastava; Mayu Koiwa; Tadahito Yasuda; Vivien Koh; Kie Kyon Huang; Su Ting Tay; Shamaine Wei Ting Ho; Angie Lay Keng Tan; Takatsugu Ishimoto; Guowei Kim; Asim Shabbir; Qingfeng Chen; Biyan Zhang; Shengli Xu; Kong-Peng Lam; Huey Yew Jeffrey Lum; Ming Teh; Wei Peng Yong; Jimmy Bok Yan So; Patrick Tan
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 39.397

5.  Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy.

Authors:  Joe Yeong; Huey Yew Jeffrey Lum; Chong Boon Teo; Wei Peng Yong; Raghav Sundar; Benjamin Kye Jyn Tan; Yiong Huak Chan; Ryan Yong Kiat Tay; Joan Rou-En Choo; Anand D Jeyasekharan; Qing Hao Miow; Lit-Hsin Loo
Journal:  Gastric Cancer       Date:  2022-06-04       Impact factor: 7.701

6.  First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.

Authors:  Yelena Y Janjigian; Kohei Shitara; Markus Moehler; Marcelo Garrido; Pamela Salman; Lin Shen; Lucjan Wyrwicz; Kensei Yamaguchi; Tomasz Skoczylas; Arinilda Campos Bragagnoli; Tianshu Liu; Michael Schenker; Patricio Yanez; Mustapha Tehfe; Ruben Kowalyszyn; Michalis V Karamouzis; Ricardo Bruges; Thomas Zander; Roberto Pazo-Cid; Erika Hitre; Kynan Feeney; James M Cleary; Valerie Poulart; Dana Cullen; Ming Lei; Hong Xiao; Kaoru Kondo; Mingshun Li; Jaffer A Ajani
Journal:  Lancet       Date:  2021-06-05       Impact factor: 79.321

7.  PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy.

Authors:  Soomin Ahn; Kyoung-Mee Kim
Journal:  Mod Pathol       Date:  2021-05-17       Impact factor: 7.842

8.  Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination.

Authors:  Raghav Sundar; Drolaiz Hw Liu; Gordon Ga Hutchins; Hayley L Slaney; Arnaldo Ns Silva; Jan Oosting; Jeremy D Hayden; Lindsay C Hewitt; Cedric Cy Ng; Amrita Mangalvedhekar; Sarah B Ng; Iain Bh Tan; Patrick Tan; Heike I Grabsch
Journal:  Gut       Date:  2020-11-23       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.